Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Tanabe (Chiba, Japan), H. Kumamaru (Tokyo, Japan), Y. Tamura (Tokyo, Japan), H. Taniguchi (Seto, Japan), N. Emoto (Kobe, Japan), Y. Yamada (Tokyo, Japan), O. Nishiyama (Osaka, Japan), I. Tsujino (Sapporo, Japan), H. Kuraishi (Nagano, Japan), H. Kimura (Kashihara, Japan), Y. Inoue (Osaka, Japan), Y. Morio (Tokyo, Japan), Y. Nakatsumi (Kanazawa, Japan), T. Satoh (Mitaka, Japan), M. Hanaoka (Matsumoto, Japan), T. Handa (Kyoto, Japan), M. Sumitani (Osaka, Japan), K. Kusaka (Kiyose, Japan), Y. Nishimura (Kobe, Japan), F. Sakamaki (Hachioji, Japan), M. Hatano (Tokyo, Japan), H. Matsubara (Okayama, Japan), K. Nakayama (Kobe, Japan), T. Kimura (Seto, Japan), S. Sakao (Chiba, Japan), M. Nishimura (Sapporo, Japan), H. Miyata (Tokyo, Japan), K. Tatsumi (Chiba, Japan). Multi-institutional prospective registry in pulmonary hypertension associated with respiratory disease in Japan.. 3098

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension associated with primary Sjögren's syndrome: a multicentre cohort study from China Source: Eur Respir J, 56 (5) 1902157; 10.1183/13993003.02157-2019 Year: 2020 Chronic pulmonary aspergillosis in France: prevalence, associated chronic pulmonary diseases and prognosis in a 10-year retrospective study of the French nationwide administrative hospital database. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Registries for paediatric pulmonary hypertension Source: Eur Respir J 2013; 42: 580-583 Year: 2013 Safety of riociguat for chronic thromboembolic pulmonary hypertension (CTEPH): Interim data from a prospective non-interventional study in Japan Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019 Year: 2019 Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010 PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016 The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study Source: Eur Respir J 2003; 22: Suppl. 45, 462s Year: 2003 Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre Source: Eur Respir J 2012; 39: 945-955 Year: 2012 Economic evaluation of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: A retrospective, case-controlled, cost of illness study Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Source: Eur Respir J 2002; 20: 1617 Year: 2002 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015 AUDIPOC. National clinical audit on chronic obstructive pulmonary disease exacerbations (eCOPD) in Spain. Experience on mechanical ventilation in patients admitted for eCOPD. Pilot study in six autonomous regions Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure Year: 2009 Pulmonary disease as a risk factor for transfusion-related acute lung injury in hospitalized patients: a nested case-control study in Japan Source: Virtual Congress 2021 – Mechanical ventilation and weaning Year: 2021 Prevalence and mechanism of pulmonary hypertension in sickle cell disease: a prospective multicentre french study Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009 Prospective study of echocardiograpy in chronic obstructive pulmonary disease in tertiary hospital Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 A multicentre observational study of the prevalence, management and outcomes of subsegmental pulmonary embolism Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 Socioeconomic position and use of drugs in chronic obstructive pulmonary disease (COPD): A population-based cohort study in Rome, Italy Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011